Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
07/07/2011 | US20110165606 Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins |
07/07/2011 | US20110165584 Variable Lymphocyte Receptors, Related Polypeptides and Nucleic Acids and Uses Thereof |
07/07/2011 | US20110165553 Vitrified composition which preserves biological materials |
07/07/2011 | US20110165305 Method for preparing a protein hydrolysate |
07/07/2011 | US20110165230 Attenuated live vaccines |
07/07/2011 | US20110165195 Composition for mucosal administration containing agent for enhancing mucosal absorption of peptide drug, and administration method thereof |
07/07/2011 | US20110165185 Immunogenic peptides |
07/07/2011 | US20110165173 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for salusin |
07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
07/07/2011 | US20110165165 Mammalian genes; related reagents and methods |
07/07/2011 | US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant |
07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
07/07/2011 | US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
07/07/2011 | US20110165145 Igf-ii/igf-iie binding proteins |
07/07/2011 | US20110165138 Protocols for treating and preventing obesity and complications arising therefrom |
07/07/2011 | US20110165132 Heparan Sulphate Which Binds BMP2 |
07/07/2011 | US20110165117 Immunogenic peptides and methods of use |
07/07/2011 | US20110165116 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
07/07/2011 | US20110165112 Polymer conjugates of c-peptides |
07/07/2011 | US20110165111 Polymer conjugates of nesiritide peptides |
07/07/2011 | US20110165083 Peptides that home to tumor lymphatic vasculature and methods of using same |
07/07/2011 | US20110165081 Psma antibodies and uses thereof |
07/07/2011 | US20110165071 Methods Of Treating Cancer |
07/07/2011 | CA2793596A1 Methods and compositions for targeted polynucleotide modification |
07/07/2011 | CA2786090A1 Interferon analogs |
07/07/2011 | CA2785992A1 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
07/07/2011 | CA2785736A1 Method for recovering bowman-birk inhibitor proteins from a soy processing stream |
07/07/2011 | CA2785607A1 Administration route for a composition to protect an animal against rhodococcus equi |
07/07/2011 | CA2785599A1 Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream |
07/07/2011 | CA2785311A1 Thermostable xylanase for the selective hydrolysis of pentose-containing polysaccharides |
07/07/2011 | CA2784757A1 Double-acylated glp-1 derivatives |
07/07/2011 | CA2784342A1 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
07/07/2011 | CA2781053A1 Simultaneous detection of mutational status and gene copy number |
07/06/2011 | EP2341350A1 Diagnostic method for brain damage-related disorders based on detection of DJ-1 |
07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
07/06/2011 | EP2341152A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
07/06/2011 | EP2341148A2 Diagnosis and treatment of cancer |
07/06/2011 | EP2341147A2 Preprimitive streak and mesendoderm cells |
07/06/2011 | EP2341144A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
07/06/2011 | EP2341143A1 OX2 receptor homolog |
07/06/2011 | EP2341142A2 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising same |
07/06/2011 | EP2341141A2 Recombinant platelet collagen receptor glycoprotein VI , antibodies and their pharmaceutical use |
07/06/2011 | EP2341138A1 FUSION PROTEIN COMPOSED OF MATRIX METALLOPROTEINASE-2 INHIBITOR PEPTIDE DERIVED FROM AMYLOID-beta PRECURSOR PROTEIN AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 |
07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
07/06/2011 | EP2341079A1 Immunoglobulin-binding proteins derived from Sac7d and uses thereof |
07/06/2011 | EP2341073A2 RAB9A, RAB11A, and modulators thereof related to infectious disease |
07/06/2011 | EP2341072A2 Method for Generating Activated T-Cells and Antigen-Pulsed Antigen-Presenting Cells |
07/06/2011 | EP2341071A1 Compostion and methods for increasing bone mineralization |
07/06/2011 | EP2341070A2 Ehanced protein expression in bacillus |
07/06/2011 | EP2341069A1 Polypeptides from non-typeable haemophilus influenzae |
07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
07/06/2011 | EP2341067A1 Specific binding agents to hepatocyte growth factor |
07/06/2011 | EP2341063A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
07/06/2011 | EP2341062A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
07/06/2011 | EP2341061A1 A novel process for preparing G-CSF (granulocyte colony stimulating factor) |
07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
07/06/2011 | EP2340851A1 Diagnosis method and therapeutic method for cancer |
07/06/2011 | EP2340845A2 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
07/06/2011 | EP2340709A1 Use of follistatin to increase muscle mass |
07/06/2011 | EP2340261A1 Amylin derivatives |
07/06/2011 | EP2340260A1 Method for isolating neural cells with tenascin-r compounds |
07/06/2011 | EP2340259A2 Novel toxin-antitoxin system |
07/06/2011 | EP2340050A2 Polymer conjugates of aod-like peptides |
07/06/2011 | EP2340049A1 Method of acylating a peptide or protein |
07/06/2011 | EP2340047A1 Polymer conjugates of kiss1 peptides |
07/06/2011 | EP2340046A2 Polymer conjugates of ziconotide peptides |
07/06/2011 | EP2340031A1 Use of gdf traps to increase red blood cell levels |
07/06/2011 | EP2340030A2 Methods, systems, and compositions for calpain inhibition |
07/06/2011 | EP2084544B1 Stable standards for bnp immunoassays |
07/06/2011 | EP1891107B1 Compositions and methods for modulating immune responses |
07/06/2011 | EP1689775B1 GAG binding proteins |
07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
07/06/2011 | EP1326885B1 Non typeable Haemophilus influenzae BASB201 polypeptides and polynucleotides and uses thereof |
07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
07/06/2011 | DE202010003498U1 Gen codiert für ein MHC-Klasse-I-Molekül, Plasmid, Expressionssystem Protein, Multimer, Reagenz und Kit zum Analysieren einer T-Zellen-Frequenz Gene encodes a MHC class I molecule, plasmid, protein expression system, multimer, reagent and kit for analyzing a T cell frequency |
07/06/2011 | CN1886521B Molecular marker associated with CMV resistance and use thereof |
07/06/2011 | CN1871022B Peptides and compounds that bind to a receptor |
07/06/2011 | CN1838965B Drug for cancer therapy |
07/06/2011 | CN1738900B Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
07/06/2011 | CN1694899B Methods for the production of methioning |
07/06/2011 | CN102119217A Novel lipid formulations for nucleic acid delivery |
07/06/2011 | CN102119172A Recombinantly produced human factor VIII and IX |
07/06/2011 | CN102119169A IQGAP3 epitope peptides and vaccines containing the same |
07/06/2011 | CN102119032A Improved cytokine design |
07/06/2011 | CN102115755A Pichia expression PCV2 (porcine circovirus 2) ORF2 (open reading frame 2) protein and subunit vaccine |
07/06/2011 | CN102115754A Application of rice phosphate transport protein gene ORYsa;Pht1;4 |
07/06/2011 | CN102115753A Plant drought-resistant related protein GpLhcb5 and coding gene and application thereof |
07/06/2011 | CN102115752A Plant drought tolerance associated protein GpRZF1 and encoding gene and application thereof |
07/06/2011 | CN102115748A Danio rerio B-lymphocyte activating factor (zBAFF) cDNA (complementary deoxyribonucleic acid), and cloning method and application thereof in recombination |
07/06/2011 | CN102115747A cDNA (complementary deoxyribonucleic acid) of horse tumor necrosis factor superfamily member 13B (horse TNFSF 13B), and cloning method, recombination and application thereof |
07/06/2011 | CN102115746A Preparation method of monodisperse magnetic human ferritin |
07/06/2011 | CN102115497A Human IgA immunoglobulin combination molecule having intramolecular affinity effect |
07/06/2011 | CN102115496A Antimicrobial peptide Pc-CATH1 and gene thereof, chemical synthesis method and application thereof |
07/06/2011 | CN102115495A Preparation method and application of protein drug for collagen targeted therapy of hyperplastic scar |
07/06/2011 | CN102115494A Tick antibacterial peptide, gene thereof and application of same |
07/06/2011 | CN102115493A Preparation method for recombinant protein G and application of same |
07/06/2011 | CN102115492A Vascular endothelial growth factor receptor partial polypeptide and application thereof |
07/06/2011 | CN101580539B Polypeptide for inducing CD4<+>CD25<+> regulatory T cells and application |
07/06/2011 | CN101111258B Emulsified composition for dilution and cancer vaccine composition |
07/06/2011 | CN101050464B Method for preparing A gene of recombined protein, and expressed products and application |